Patents by Inventor Stephen Pawsey

Stephen Pawsey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL USES
    Publication number: 20240108621
    Abstract: This invention relates to the new use of neurokinin-1 receptor antagonists as a treatment of pulmonary fibrosis conditions promoted by mechanical injury to the lungs. Specifically, when the mechanical injury to the lungs is induced by mechanical ventilation or by the act of coughing in a subset of patients with pulmonary fibrosis conditions who cough. The invention further relates to pharmaceutical compositions comprising neurokinin-1 receptor antagonist drugs and to combinations for such uses.
    Type: Application
    Filed: November 28, 2023
    Publication date: April 4, 2024
    Applicant: NeRRe Therapeutics Limited
    Inventors: Mike Trower, Stephen Pawsey, Mary Kerr
  • Uses
    Patent number: 11872222
    Abstract: This invention relates to the new use of neurokinin-1 receptor antagonists as a treatment of pulmonary fibrosis conditions promoted by mechanical injury to the lungs. Specifically, when the mechanical injury to the lungs is induced by mechanical ventilation or by the act of coughing in a subset of patients with pulmonary fibrosis conditions who cough. The invention further relates to pharmaceutical compositions comprising neurokinin-1 receptor antagonist drugs and to combinations for such uses.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: January 16, 2024
    Assignee: NeRRe Therapeutics Limited
    Inventors: Mike Trower, Stephen Pawsey, Mary Kerr
  • NOVEL USES
    Publication number: 20210369707
    Abstract: This invention relates to the new use of neurokinin-1 receptor antagonists as a treatment of pulmonary fibrosis conditions promoted by mechanical injury to the lungs. Specifically, when the mechanical injury to the lungs is induced by mechanical ventilation or by the act of coughing in a subset of patients with pulmonary fibrosis conditions who cough. The invention further relates to pharmaceutical compositions comprising neurokinin-1 receptor antagonist drugs and to combinations for such uses.
    Type: Application
    Filed: May 28, 2021
    Publication date: December 2, 2021
    Applicant: NeRRe Therapeutics Limited
    Inventors: Mike Trower, Stephen Pawsey, Mary Kerr